BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27532155)

  • 21. Mortality and Vascular Events Among Elderly Patients With Chronic Myeloid Leukemia: A Retrospective Analysis of Linked SEER-Medicare Data.
    Lang K; McGarry LJ; Huang H; Dorer D; Kaufman E; Knopf K
    Clin Lymphoma Myeloma Leuk; 2016 May; 16(5):275-285.e1. PubMed ID: 27013180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing the economic burden of Alzheimer's disease patients first diagnosed by specialists.
    Kirson NY; Desai U; Ristovska L; Cummings AK; Birnbaum HG; Ye W; Andrews JS; Ball D; Kahle-Wrobleski K
    BMC Geriatr; 2016 Jul; 16():138. PubMed ID: 27400711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The real world effectiveness of hematopoietic transplant among elderly individuals with multiple myeloma.
    Winn AN; Shah GL; Cohen JT; Lin PJ; Parsons SK
    J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 26023094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determining the clinical significance of monoclonal gammopathy of undetermined significance: a SEER-Medicare population analysis.
    Go RS; Gundrum JD; Neuner JM
    Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):177-186.e4. PubMed ID: 25445471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of skeletal complications and treatment patterns associated with early vs. delayed zoledronic acid therapy in multiple myeloma.
    Wu EQ; Bensimon AG; Marynchenko M; Namjoshi M; Guo A; Yu AP; Ericson SG; Raje N
    Clin Lymphoma Myeloma Leuk; 2011 Aug; 11(4):326-35. PubMed ID: 21700528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of comorbidity on mortality in multiple myeloma: a Danish nationwide population-based study.
    Gregersen H; Vangsted AJ; Abildgaard N; Andersen NF; Pedersen RS; Frølund UC; Helleberg C; Broch B; Pedersen PT; Gimsing P; Klausen TW
    Cancer Med; 2017 Jul; 6(7):1807-1816. PubMed ID: 28639741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utilization of novel systemic therapies for multiple myeloma: A retrospective study of front-line regimens using the SEER-Medicare data.
    Goto D; Khairnar R; Yared JA; Yong C; Romanus D; Onukwugha E; Slejko JF
    Cancer Med; 2020 Jan; 9(2):626-639. PubMed ID: 31801177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy and survival for patients with multiple myeloma: findings from a large nationwide and population-based cohort.
    Rohatgi N; Du XL; Coker AL; Moye LA; Wang M; Fang S
    Am J Clin Oncol; 2007 Oct; 30(5):540-8. PubMed ID: 17921717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.
    Iezzoni LI; Ngo LH; Li D; Roetzheim RG; Drews RE; McCarthy EP
    Arch Phys Med Rehabil; 2008 Apr; 89(4):595-601. PubMed ID: 18373987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cataract Surgery and Mortality in the United States Medicare Population.
    Tseng VL; Yu F; Lum F; Coleman AL
    Ophthalmology; 2016 May; 123(5):1019-26. PubMed ID: 26854033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients.
    Engelhardt M; Domm AS; Dold SM; Ihorst G; Reinhardt H; Zober A; Hieke S; Baayen C; Müller SJ; Einsele H; Sonneveld P; Landgren O; Schumacher M; Wäsch R
    Haematologica; 2017 May; 102(5):910-921. PubMed ID: 28154088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Real-world treatment patterns, comorbidities, and disease-related complications in patients with multiple myeloma in the United States.
    Song X; Cong Z; Wilson K
    Curr Med Res Opin; 2016; 32(1):95-103. PubMed ID: 26488820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations of depression diagnosis and antidepressant treatment with mortality among young and disabled Medicare beneficiaries with COPD.
    Qian J; Simoni-Wastila L; Rattinger GB; Lehmann S; Langenberg P; Zuckerman IH; Terrin M
    Gen Hosp Psychiatry; 2013; 35(6):612-8. PubMed ID: 23871313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of 30-Day All-Cause Readmission with Long-Term Outcomes in Hospitalized Older Medicare Beneficiaries with Heart Failure.
    Arundel C; Lam PH; Khosla R; Blackman MR; Fonarow GC; Morgan C; Zeng Q; Fletcher RD; Butler J; Wu WC; Deedwania P; Love TE; White M; Aronow WS; Anker SD; Allman RM; Ahmed A
    Am J Med; 2016 Nov; 129(11):1178-1184. PubMed ID: 27401949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative Effectiveness of Carotid Artery Stenting Versus Carotid Endarterectomy Among Medicare Beneficiaries.
    Jalbert JJ; Nguyen LL; Gerhard-Herman MD; Kumamaru H; Chen CY; Williams LA; Liu J; Rothman AT; Jaff MR; Seeger JD; Benenati JF; Schneider PA; Aronow HD; Johnston JA; Brott TG; Tsai TT; White CJ; Setoguchi S
    Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):275-85. PubMed ID: 27116974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sleep apnea testing and outcomes in a large cohort of Medicare beneficiaries with newly diagnosed heart failure.
    Javaheri S; Caref EB; Chen E; Tong KB; Abraham WT
    Am J Respir Crit Care Med; 2011 Feb; 183(4):539-46. PubMed ID: 20656940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial.
    Gay F; Oliva S; Petrucci MT; Conticello C; Catalano L; Corradini P; Siniscalchi A; Magarotto V; Pour L; Carella A; Malfitano A; Petrò D; Evangelista A; Spada S; Pescosta N; Omedè P; Campbell P; Liberati AM; Offidani M; Ria R; Pulini S; Patriarca F; Hajek R; Spencer A; Boccadoro M; Palumbo A
    Lancet Oncol; 2015 Dec; 16(16):1617-29. PubMed ID: 26596670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-reported health and survival in older patients diagnosed with multiple myeloma.
    Nabulsi NA; Alobaidi A; Talon B; Asfaw AA; Zhou J; Sharp LK; Sweiss K; Patel PR; Ko NY; Chiu BC; Calip GS
    Cancer Causes Control; 2020 Jul; 31(7):641-650. PubMed ID: 32356139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early mortality in multiple myeloma: Experiences from a single institution.
    Chen YK; Han SM; Yang Y; Lin TH; Tzeng HE; Chang KH; Hwang WL; Teng CL
    Hematology; 2016 Aug; 21(7):392-8. PubMed ID: 26868131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone.
    Graham DJ; Ouellet-Hellstrom R; MaCurdy TE; Ali F; Sholley C; Worrall C; Kelman JA
    JAMA; 2010 Jul; 304(4):411-8. PubMed ID: 20584880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.